UMD Catalyst Grant: Maaike Oosterveer
Liver disease, in particular hepatic tumorigenesis, represent a serious long-term complication in adult patients suffering from Glycogen Storage Disease type 1a (GSD Ia). Current dietary management primarily aims to prevent life-threatening hypoglycemia, and does generally not prevent liver disease. It is therefore critical to explore novel therapeutic strategies.
In this collaborative and preclinical research project Dr. Maaike Oosterveer (UMCG Laboratory of Pediatrics) and Prof. Dr. Riekelt Houtkooper (AMC Laboratory of Genetic Metabolic Diseases) will investigate the impact of dietary supplementation on development of liver disease in GSD Ia.
https://www.unitedformetabolicdiseases.nl/english/home.html
| Last modified: | 21 September 2020 11.08 a.m. |
More news
-
02 July 2025
Relinde Weil reappointed as a member of the Supervisory Board UG
The Minister of Education has reappointed Relinde Weil for a second term as a member of the Supervisory Board of the University of Groningen.
-
-
01 July 2025
Khalaf Alkhalaf elected Alumnus of the Year 2025
Khalaf Alkhalaf has been elected Alumnus of the Year 2025 by the University of Groningen. He has received the award for his commitment to providing good care and guidance to refugees in the Netherlands and the inspiring way in which he shares his...